Pharmacology, Toxicology and Pharmaceutical Science
Enzyme Inhibition
100%
Receptor
100%
Angiotensin II
100%
Fibrinolytic Agent
100%
Dipeptidyl Carboxypeptidase
100%
Losartan
100%
Quinapril
100%
Table Salt
60%
Plasminogen Activator Inhibitor 1
50%
Aldosterone
40%
Dipeptidyl Carboxypeptidase Inhibitor
30%
Tissue Plasminogen Activator
30%
Renin
30%
Angiotensin
20%
Angiotensin 1 Receptor Antagonist
10%
Bradykinin
10%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Enzyme Inhibition
100%
Plasminogen Activator Inhibitor-1
100%
Angiotensin II Receptor Type 1
100%
Blood Plasma
100%
Angiotensin
80%
Enzyme Inhibitor
60%
Tissue Plasminogen Activator
60%
Blood Pressure
40%
Renin Angiotensin Aldosterone System
40%
Aldosterone
40%
Plasma Renin Activity
20%
Body Mass
20%
Receptor Antagonist
20%
Systolic Blood Pressure
20%
Fibrinolysis
20%
Bradykinin
20%
Keyphrases
Receptor Antagonism
100%
Losartan
100%
Angiotensin-converting Enzyme Inhibition
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Quinapril
100%
Low Salt
60%
Plasminogen Activator inhibitor-1 (PAI-1)
50%
Tissue Plasminogen Activator (t-PA)
30%
Angiotensin-converting Enzyme Inhibitor (ACEi)
30%
Salt Intake
30%
Renin-angiotensin-aldosterone System
20%
Antigen Concentration
20%
Aldosterone
20%
Angiotensin II Type 1
20%
Heart Rate
10%
Blood Pressure
10%
Clinical Significance
10%
Fibrinolysis
10%
Body Mass Index
10%
Angiotensin II (Ang II)
10%
Systolic Blood Pressure
10%
Plasma Renin Activity
10%
Blood Pressure Lowering
10%
Drug Class
10%
Contrast Effect
10%
Bradykinin
10%
Plasma Tissue
10%
Angiotensin II Type 1 Receptor Antagonist
10%